These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2201157)

  • 1. [Changes in the activity of the natural killers under the influence of genetically engineered alpha 2-interferon in patients with viral hepatitis B].
    Malinovskaia VV; Murzabaeva RT; Bragina GS
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):97-101. PubMed ID: 2201157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B].
    Petrovskaia IA; Kushko LIa; Fedorchenko SV; Vovk AD; Listopad NK; Antoniak SN; Drannik GN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):56-7. PubMed ID: 8553758
    [No Abstract]   [Full Text] [Related]  

  • 3. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment].
    Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM
    Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the interferon status of patients with viral hepatitis B when genetically engineered alpha 2-interferon is used].
    Pokrovskiĭ VI; Malinovskaia VV; Murzabaeva RT; Vasil'eva VI; Asratian AA
    Vopr Virusol; 1990; 35(2):135-8. PubMed ID: 2117831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B].
    Pokrovskiĭ VI; Zmyzgova AV; Matveeva SM; Saltykov VP; Soibnazarov ISh
    Ter Arkh; 1986; 58(10):29-32. PubMed ID: 3798344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An assessment of the therapeutic efficacy of gene-engineered human alpha 2-interferon in patients with acute viral hepatitis B].
    Pokrovskiĭ VI; Zmyzgova AV; Botsvadze ESh; Andreĭchin MA; Frolov VM; Murzabaeva RT; Mesniankin AP; Kokareva LN; Malinovskaia VV
    Ter Arkh; 1990; 62(2):139-43. PubMed ID: 2186494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of reaferon in treating patients with protracted viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Nazarenko IV
    Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B].
    Andreĭchin MA; Rudchik AS; Borak VF
    Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in interferon status in patients with acute viral hepatitis during intramuscular and rectal administration of genetically engineered alpha-2-interferon].
    Malinovskaia VV; Neumoina MV; Budanov SV
    Vopr Virusol; 1994; 39(6):269-72. PubMed ID: 7536374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer activity in patients with acute viral hepatitis.
    Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G
    Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of using recombinant interferon alfa2 (reaferon) combined with antioxidants in children with acute hepatitis B].
    Reĭzis AR; Malinovskaia VV; Shekhade S; Drondina AK; Nikitina TS; Markarian AS; Nazarenko IV; Mikhaĭlov MI
    Pediatriia; 1992; (1):60-4. PubMed ID: 1614804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune modulation of natural killer cell cytotoxicity against herpes infected target cells in pregnancy.
    Gonik B; Loftin KC; Tan NS; Crump J
    Am J Reprod Immunol; 1990 Dec; 24(4):95-8. PubMed ID: 2085395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reaferon and interferonogenes in the therapy of acute viral hepatitis B].
    Andreĭchin MA; Zmyzgova AV; Rudchik AS
    Klin Med (Mosk); 1991 Mar; 69(3):77-80. PubMed ID: 2067345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The reaferon treatment of a patient with acute viral hepatitis B and hemorrhagic vasculitis].
    Fedorchenko SV; Tereshchenko TM
    Vrach Delo; 1990 Oct; (10):104-5. PubMed ID: 2080557
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Change in the activity of natural killer cells in normal subjects and in virus diseases on exposure to interferon in vitro].
    Petrov RV; Saidov MZ; Koval'chuk LV; Sorokin AM; Kaganov BS
    Biull Eksp Biol Med; 1984 Apr; 97(4):438-40. PubMed ID: 6722306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy.
    Actis GC; Maran E; Rosina F; Saracco G; Rocca G; Rizzetto M; Bonino F; Verme G
    Digestion; 1987; 37(1):51-8. PubMed ID: 3609505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody-dependent cell cytotoxicity and the effect of interferon on K-cell functional activity in vitro in chronic viral hepatitis B in children].
    Kaganov BS; Zimin IuI; Uchaĭkin VF; Saidov MZ; Sorokin AM
    Biull Eksp Biol Med; 1984 Dec; 98(12):700-2. PubMed ID: 6509200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natural killer activity in influenza patients].
    Savitskiĭ GI; Grishchenko SV; Krylov VF; Kolobukhina LV; Kniazeva LD
    Vopr Virusol; 1988; 33(3):290-2. PubMed ID: 3176429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.